Abstract
Pain is a key component of most rheumatologic diseases. In fibromyalgia, the importance of central nervous system pain mechanisms (for example, loss of descending analgesic activity and central sensitization) is well documented. A few studies have also noted alterations in central pain processing in osteoarthritis, and some data, including the observation of widespread pain sensitivity, suggest that central pain-processing defects may alter the pain response in rheumatoid arthritis patients. When central pain is identified, different classes of analgesics (for example, serotonin-norepinephrine reuptake inhibitors, α2δ ligands) may be more effective than drugs that treat peripheral or nociceptive pain (for example, nonsteroidal anti-inflammatory drugs and opioids).
| Original language | English (US) |
|---|---|
| Article number | 211 |
| Journal | Arthritis Research and Therapy |
| Volume | 13 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 28 2011 |
Funding
Grant support was received from NIH/NIAMS grant AR057578. The funding body played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.
ASJC Scopus subject areas
- Rheumatology
- Immunology and Allergy
- Immunology